Sign inJoin waitlistJoin the waitlist

Juan Cata

Associate Professor, Department of Anesthesiology and Perioperative Medicine · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present

Anesthesiology
Cleveland Clinic Foundation
2006–2007
Pain Medicine Research Training
University of Texas M D Anderson Cancer Center
2002–2005
Hospital Privado De Cordoba
1998–2001
Doctor of Medicine
1993–1997

Research

Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions
Review · British Journal of Anaesthesia · 2013 · First of 5 authors · Corresponding · 363 citations
Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis
Review · Clinical and Translational Medicine · 2023 · 352 citations
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients
Pain · 2004 · 304 citations

VG
Vijaya Gottumukkala
38 papers
PO
Pascal Owusu-Agyemang
27 papers
Daniel Sessler
21 papers
Jose Soliz
17 papers
Eduardo Nunez
16 papers · 10 as a resident
JL
Juan Guerra Londono
16 papers · 12 as a resident
Javier Lasala
15 papers
NC
Nicolas Cortes-Mejia
15 papers · 12 as a resident
Germán Corrales
14 papers · 8 as a resident
Gabriel Mena
13 papers · 1 as a resident
Katherine Hagan
12 papers · 2 as a resident
Ravish Kapoor
12 papers

Grants

An Augmented Reality Platform to Reduce Post-Operative and Chronic Opioid Use in Pediatric Cancer
National Institute on Drug Abuse · R42
PI · $2.1M · Altality, Inc.
2020–2024
Feasibility of a Dual English/Spanish Mobile Augmented Reality Pain Assessment App to Reduce Postoperative Prescription Opioid Use in Hispanic/Latino Pediatric and Adolescent Cancer Patients
National Institute on Drug Abuse · R43
PI · $311K · Altality, Inc.
2022–2023

Clinical trials

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.
Principal investigator · Recruiting · Phase 4
M.D. Anderson Cancer Center
2024–2026
A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.
Principal investigator · Completed
M.D. Anderson Cancer Center
2023–2025
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use
Principal investigator · Withdrawn · Phase 2
M.D. Anderson Cancer Center
2022–2024
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
2022–2026